Back

The central response of electroacupuncture for anxiety in people with obesity based on resting-state functional magnetic resonance imaging: a protocol for a randomized, blinded, sham-controlled trial

Shu, Q.; Peng, q.; Duan, w.; Zhang, F.; YU, Q.; CAI, R.-l.

2024-09-22 neurology
10.1101/2024.09.19.24313948 medRxiv
Show abstract

IntroductionObesity is a problem that is increasing worldwide and anxiety is a major psychological disorder associated with obesity. Electroacupuncture (EA) has been proved to be a feasible treatment for obesity and anxiety respectively in clinical practice. However, to date, there are no data on EAs effectiveness on anxiety for people with obesity. Therefore, this study aims to evaluate the efficacy and safety of EA for anxiety in people with obesity, and to observe the brain functional status of patients and the intervention effects of EA on brain function by functional magnetic resonance imaging (fMRI). Methods and analysisThis study is a randomized, blinded, sham-controlled and clinical trial. 72 obesity patients from two hospitals with anxiety will be randomly divided into EA group and control group in 1:1 ratio by using a random number table. Patients in EA group will receive EA treatment at specific acupoints with penetrating needling for 8 weeks. The control group will receive Parks acupuncture with non- penetrating needling. Weight, waist, BMI (Body Mass Index), SAS (Self-rating Anxiety Scale), STAI (State-Trait Anxiety Inventory) and PSQI (Pittsburgh Sleep Quality Index) will be performed before, after 8-week treatments and at one-month follow-up in patients. Objective metabolic parameters such as triglyceride, total cholesterol, fasting blood glucose, ghrelin, leptin, cortisol and adrenocorticotropic hormone will also be detected before and after 8-week intervention. 20 patients will be randomly selected from EA group and control group, respectively, before treatment, and 20 paired healthy participants will be recruited at the same time. The 20 patients will be scanned by fMRI before and after treatment while the other 20 healthy participants will be scanned only at baseline. Regional homogeneity, amplitude of low-frequency fluctuation and resting-state-functional-connectivity will be carried out to compare the dysfunctional brain regions between patients and healthy participants, as well as the differences between two groups of patients after treatment. Ethics and disseminationThe study protocol has been approved by the Hospital Ethics Committee of Second Affiliated Hospital of Anhui University of Chinese Medicine (2023-zj-42). Informed consent will be obtained prior to starting study- ralated procedures. The results will be disseminated in peer-reviewed journals and at scientific conferences. Trail Registration numberChinese Clinical Trail Registry. ChiCTR2400083594, registered 29 April 2024.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.